HTS 3002.15.00Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified:Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: Immunological products, put up in measured doses or in forms or packings for retail sale

What that translates to:Immunological products in measured doses or retail packs

Also written 30021500. Rates as CBP is collecting them today. Updated Oct 1, 2026.

Country of origin

Immunological products in measured doses or retail packs (HTS 3002.15.00) from China, as of Oct 1, 2026: the patented-medicine tariff (Section 232) applies only to goods that match its legal description, quoted below, so the total depends on your product.

Total duty rateDepends on the product

Regular dutyBase rate (MFN) in the tariff scheduleFree

Total dutyDepends on the product

No forced-labor tariff on this product: it's on the tariff's exemption list (HTS 9903.05.86).

Instead, the patented-medicine tariff adds 20% where this applies: “patented pharmaceutical articles imported for companies subject to an onshoring plan approved by the Secretary of Commerce in accordance with a process to be established in a Federal Register notice” (HTS 9903.04.64).

The patented-medicine tariff may not apply. The legal text: “patented pharmaceutical articles that meet the requirements of subdivision (h)(i) of this note and are imported for companies that have entered into a Most-Favored-Nation pharmaceutical pricing agreement with the Secretary of Health and Human Services” (HTS 9903.04.65).

The patented-medicine tariff may not apply. The legal text: “drugs and associated ingredients for all approved indications that are designated as orphan pursuant to the Orphan Drug Act, 21 U.S.C. 360aa et seq. and its implementing regulations; nuclear medicines; plasma-derived therapies; fertility treatments; cell and gene therapies; antibody drug conjugates; medical countermeasures related to chemical, biological, radiological and nuclear threats; or other specialty pharmaceutical products identified by the Secretary of Commerce or pharmaceutical products for animal health imported from a jurisdiction that has a current or forthcoming trade and security framework or that meet an urgent U.S. health need” (HTS 9903.04.66).

The patented-medicine tariff doesn't apply to “Pharmaceutical products with an active pharmaceutical ingredient packaged in dosage form that is a product of the United States” (HTS 9903.04.68).

The patented-medicine tariff may not apply. The legal text: “Pharmaceutical articles and associated ingredients provided for in subdivision (c) of U.S. note 40 to this subchapter that are solely for use in clinical trials, research and development, or other non-commercial applications” (HTS 9903.04.70).

The patented-medicine tariff is 100% in place of the regular duty where this applies: “patented pharmaceutical articles provided for in subdivision (c) of this note” (HTS 9903.04.60).

Sources: USITC Harmonized Tariff Schedule, Revision 20 (2026).

Estimate your duty

Special rules apply to this code or country, so we don't estimate it here. A licensed customs broker can work it out for your shipment.

Importing under HTS 3002.15.00? Talk to a licensed broker

Classification, filing, customs bonds and refund help. CBP publishes the brokers permitted at each port.

Find a licensed broker

Opens CBP's list of permitted customs brokers. We're not paid for this link.

Details for customs filings

Official description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: Immunological products, put up in measured doses or in forms or packings for retail sale

Legal text from the Harmonized Tariff Schedule, Revision 20 (2026), chapter 30: Pharmaceutical products.

Statistical lines

The 10-digit numbers used on entry paperwork. They share this code's duty rates.

3002.15.0011 (3002150011)Containing monoclonal antibodies · reported in kg
3002.15.0091 (3002150091)Other · reported in kg

What changed for this code

Sep 29, 2026Section 232 tariff on patented medicines starts for all other companies
Jul 31, 2026Section 232 tariff on patented medicines starts for listed companies
Jul 24, 2026Forced-labor tariffs start on imports from 60 economies (Section 301)
Jul 22, 202625% Section 301 tariff on products of Brazil starts
Jan 1, 2026Section 301 tariff on Nicaragua starts at 0%, set to rise to 10% in 2027 and 15% in 2028

Questions about HTS 3002.15.00

What is the duty rate for HTS 3002.15.00?

The regular (column 1 general) rate printed in the tariff schedule is Free. Additional tariffs depend on the country of origin; choose one above to see its full rate.

Is HTS 3002.15.00 subject to Section 301 tariffs?

Yes, for goods from 1 country as of Oct 1, 2026: Nicaragua. Choose a country above to see the rate and any exemptions.

Is HTS 3002.15.00 subject to Section 232 tariffs?

No Section 232 tariff applies to HTS 3002.15.00 as of Oct 1, 2026, from any country of origin.

HTSLookup shows the duties CBP collects on this code by country of origin. Antidumping or countervailing duties may also apply to some exporters; they're set per company and aren't shown.